Financial reports
10-Q
2024 Q3
Quarterly report
8 Feb 24
10-Q
2024 Q2
Quarterly report
13 Nov 23
10-Q
2024 Q1
Quarterly report
10 Aug 23
10-K
2023 FY
Annual report
21 Jun 23
10-Q
2023 Q3
Quarterly report
14 Feb 23
10-Q
2023 Q2
Quarterly report
14 Nov 22
10-Q
2023 Q1
Quarterly report
11 Aug 22
10-K
2022 FY
Annual report
13 Jul 22
NT 10-K
Notice of late annual filing
29 Jun 22
10-Q
2022 Q3
Quarterly report
11 Feb 22
Current reports
8-K
Regulation FD Disclosure
9 Apr 24
8-K
Sonoma Pharmaceuticals, Inc. Investor Presentation April 2024
2 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Mar 24
8-K
Entry into a Material Definitive Agreement
8 Mar 24
8-K
Sonoma Pharmaceuticals, Inc. Investor Presentation January 2024
10 Jan 24
8-K
Entry into a Material Definitive Agreement
9 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Entry into a Material Definitive Agreement
15 Dec 23
8-K/A
Sonoma Pharmaceuticals, Inc. Investor Presentation October 2023
11 Oct 23
8-K
Sonoma Pharmaceuticals, Inc. Investor Presentation October 2023
11 Oct 23
Registration and prospectus
424B3
Prospectus supplement
8 Mar 24
424B3
Prospectus supplement
15 Dec 23
424B5
Prospectus supplement for primary offering
22 Nov 23
S-3
Shelf registration
3 Nov 23
424B4
Prospectus supplement with pricing info
30 Oct 23
S-1/A
IPO registration (amended)
13 Oct 23
S-1
IPO registration
19 Sep 23
424B5
Prospectus supplement for primary offering
24 Feb 23
424B3
Prospectus supplement
23 Dec 22
S-8
Registration of securities for employees
13 Jan 22
Proxies
DEFA14A
Additional proxy soliciting materials
14 Sep 23
DEF 14A
Definitive proxy
27 Jul 23
DEF 14A
Definitive proxy
22 Jul 22
DEFA14A
Additional proxy soliciting materials
30 Aug 21
DEFA14A
Additional proxy soliciting materials
23 Aug 21
DEFA14A
Additional proxy soliciting materials
16 Aug 21
DEF 14A
Definitive proxy
29 Jul 21
DEF 14A
Definitive proxy
29 Jul 20
DEFA14A
Additional proxy soliciting materials
18 Oct 19
DEFA14A
Additional proxy soliciting materials
9 Oct 19
Other
EFFECT
Notice of effectiveness
21 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
7 Nov 23
EFFECT
Notice of effectiveness
27 Oct 23
CORRESP
Correspondence with SEC
24 Oct 23
CORRESP
Correspondence with SEC
24 Oct 23
CORRESP
Correspondence with SEC
13 Oct 23
UPLOAD
Letter from SEC
27 Sep 23
EFFECT
Notice of effectiveness
23 Dec 20
CORRESP
Correspondence with SEC
18 Dec 20
Ownership